Prestige BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '25 Jun 26, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Market Capitalization	143,630	103,966	113,582	137,620	396,635	-	Upgrade
Market Cap Growth	55.01%	-8.47%	-17.47%	-65.30%	-	-	Upgrade
Enterprise Value	177,144	44,042	-6,736	-150,494	-63,944	-	Upgrade
Last Close Price	11950.00	8650.00	9450.00	11450.00	33000.00	-	Upgrade
PE Ratio	33.03	-	6.47	-	-	-	Upgrade
Forward PE	-	12.01	12.01	12.01	-	-	Upgrade
PS Ratio	16.58	150.88	701.81	-	-	-	Upgrade
PB Ratio	0.27	0.20	0.21	0.32	0.69	-	Upgrade
P/TBV Ratio	0.36	0.26	0.28	0.32	0.69	-	Upgrade
EV/Sales Ratio	20.45	63.92	-	-	-	-	Upgrade
Debt / Equity Ratio	0.27	0.20	0.21	0.01	0.01	0.02	Upgrade
Debt / EBITDA Ratio	-	-	9.11	-	-	-	Upgrade
Asset Turnover	0.01	0.00	0	-	-	-	Upgrade
Inventory Turnover	0.08	0.10	0.01	-	-	-	Upgrade
Quick Ratio	1.23	1.57	2.24	7.26	32.70	5.71	Upgrade
Current Ratio	1.38	1.72	2.31	7.46	32.74	5.88	Upgrade
Return on Equity (ROE)	0.04%	-10.38%	-0.59%	-42.08%	-2.07%	-15.29%	Upgrade
Return on Assets (ROA)	-5.17%	-5.35%	0.10%	-13.89%	-3.01%	-6.12%	Upgrade
Return on Capital (ROIC)	-5.90%	-6.07%	0.12%	-15.08%	-3.18%	-7.41%	Upgrade
Return on Capital Employed (ROCE)	-	-	0.20%	-	-	-	Upgrade
Earnings Yield	15.17%	-31.66%	15.47%	-153.65%	-1.86%	-	Upgrade
FCF Yield	-68.90%	-65.49%	-95.65%	-74.36%	-4.13%	-	Upgrade
Buyback Yield / Dilution	-0.07%	-	-	-16.46%	-20.98%	-7.27%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.